<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-23T13:54:43+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>每月一次的长效纳米晶制剂获得FDA批准用于艾滋病治疗</title>
    <updated>2021-01-23T13:12:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-23:/s/XrHIZpMm1KKWtD4V1H6TXw</id>
    <link href="https://mp.weixin.qq.com/s/XrHIZpMm1KKWtD4V1H6TXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新公众号“药海书香”，期待各位大佬的关注</title>
    <updated>2021-01-23T13:12:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-23:/s/RNwalYTeaIdogiSTatTCyg</id>
    <link href="https://mp.weixin.qq.com/s/RNwalYTeaIdogiSTatTCyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>壳聚糖在药物制剂中的应用</title>
    <updated>2021-01-22T08:08:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/qIebmjRyO9SjRU1ctBu-TQ</id>
    <link href="https://mp.weixin.qq.com/s/qIebmjRyO9SjRU1ctBu-TQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年第一响：FDA批准新型抗心衰药​Vericiguat</title>
    <updated>2021-01-22T08:08:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/0rmTphlRRR7iAcmyHjw44g</id>
    <link href="https://mp.weixin.qq.com/s/0rmTphlRRR7iAcmyHjw44g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仿制药竞争依然激烈，不会布局，必将淘汰</title>
    <updated>2021-01-22T08:08:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/meqiu91Vb0QJPLVL2p3kHQ</id>
    <link href="https://mp.weixin.qq.com/s/meqiu91Vb0QJPLVL2p3kHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>读罗氏发家史：全球最大生物制药与诊断巨头是如何炼成的</title>
    <updated>2021-01-20T19:57:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/qfqGAzks5NSDZnmeXzHM4g</id>
    <link href="https://mp.weixin.qq.com/s/qfqGAzks5NSDZnmeXzHM4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干法制粒机有奖问卷调研，点击参与</title>
    <updated>2021-01-20T19:57:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/eL7g3hfXX0y7IbURwWOGyw</id>
    <link href="https://mp.weixin.qq.com/s/eL7g3hfXX0y7IbURwWOGyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>万变不离其宗的药品价格管理</title>
    <updated>2021-01-20T19:57:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/lgDbCxqv4B7GuQ_m7I1Tjg</id>
    <link href="https://mp.weixin.qq.com/s/lgDbCxqv4B7GuQ_m7I1Tjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杂质的控制点和控制策略</title>
    <updated>2021-01-20T19:57:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/kUiTcO0KFY_vttPrvd47xA</id>
    <link href="https://mp.weixin.qq.com/s/kUiTcO0KFY_vttPrvd47xA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基于Xgboost算法降低质量成本</title>
    <updated>2021-01-20T10:12:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/V5wz4do5HFBOv_D4yb10sg</id>
    <link href="https://mp.weixin.qq.com/s/V5wz4do5HFBOv_D4yb10sg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未知杂质定性之液质图谱中分子量的解析原则</title>
    <updated>2021-01-20T10:12:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/QQLu8r6l6tYeM6THUcffkQ</id>
    <link href="https://mp.weixin.qq.com/s/QQLu8r6l6tYeM6THUcffkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅析影响制剂稳定性的因素</title>
    <updated>2021-01-20T10:12:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/-SG1BJd6lLDPAl_xja3qBA</id>
    <link href="https://mp.weixin.qq.com/s/-SG1BJd6lLDPAl_xja3qBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物晶体粉末XRD图谱分析</title>
    <updated>2021-01-18T21:46:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/qBVpysroN5FU0rdlwoHyUg</id>
    <link href="https://mp.weixin.qq.com/s/qBVpysroN5FU0rdlwoHyUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>网络研讨会丨行业大咖为您解析儿科临床研究</title>
    <updated>2021-01-18T21:46:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/OB5CA9UFKy14sijRq1avkQ</id>
    <link href="https://mp.weixin.qq.com/s/OB5CA9UFKy14sijRq1avkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采：总采购规模及“缩水”程度分析</title>
    <updated>2021-01-18T21:46:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/GLX_Mkl4K221KdrkGGV22Q</id>
    <link href="https://mp.weixin.qq.com/s/GLX_Mkl4K221KdrkGGV22Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高效液相色谱法-基础篇</title>
    <updated>2021-01-18T21:46:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/boZrvjQl_8FY-3v3X7PJtg</id>
    <link href="https://mp.weixin.qq.com/s/boZrvjQl_8FY-3v3X7PJtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>万字长文，帮你厘清非小细胞肺癌靶向治疗的新前景</title>
    <updated>2021-01-17T20:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/ZFrY9aBXNwG2LxaYb7fOqA</id>
    <link href="https://mp.weixin.qq.com/s/ZFrY9aBXNwG2LxaYb7fOqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CAR-T疗法，即将上市；多个重磅注射剂通过一致性评价</title>
    <updated>2021-01-17T20:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/1r0hTBL5ZVs6pF7da8JwkQ</id>
    <link href="https://mp.weixin.qq.com/s/1r0hTBL5ZVs6pF7da8JwkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人人学懂免疫学：第十七期</title>
    <updated>2021-01-17T20:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/naMBFc3WLSzBFtfdVf1k1g</id>
    <link href="https://mp.weixin.qq.com/s/naMBFc3WLSzBFtfdVf1k1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>读Medicines公司发家故事：临床失败项目巧妙二次复活，变废为宝，铸就成功</title>
    <updated>2021-01-17T20:41:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-9H59kaZfp9i3a1Ox76bLA</id>
    <link href="https://mp.weixin.qq.com/s/-9H59kaZfp9i3a1Ox76bLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>